Trial intelligence / Profile preview

Losartan for Knee Osteoarthritis with Moderate Hypertension

ChiCTR2000035247Phase 4Not yet recruiting

Sponsor
Shenzhen Second People's Hospital
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) and hypertension (HTN) comparing Losartan arm with Placebo arm (2 arms). Primary endpoints: WOMAC pain score and VAS pain score. Planned start Aug 2020; status: not yet recruiting.

02

Drugs

losartan
03

Conditions

knee osteoarthritis (OA)hypertension (HTN)

Beyond the preview

Go deeper on ChiCTR2000035247.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000035247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call